Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported AMPH revenue for 2026-06-30 was $355.1M. Net income was $36.8M. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Use this AMPH page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AMPH quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AMPH SEC filings page. Lician reads the product cache first so this HTML stays unique to Amphastar P even when a live quote feed is slow.
Latest cached year on this hub. Full AMPH income, balance, and cash tables.